Literature DB >> 13704653

Effect of estrogens on copper metabolism in Wilson's disease.

J L GERMAN, A G BEARN.   

Abstract

Entities:  

Keywords:  COPPER/metabolism; ESTRADIOL/pharmacology; HEPATOLENTICULAR DEGENERATION/metabolism

Mesh：

Substances：

Year:  1961        PMID： 13704653      PMCID： PMC290741          DOI： 10.1172/JCI104272

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

1.  Some current speculations on the action of estrogens.

Authors:  C A VILLEE
Journal:  Perspect Biol Med       Date:  1959       Impact factor: 1.416

2.  Changing concepts of the pathogenesis of Wilson's disease.

Authors:  J M WALSHE
Journal:  Ann Intern Med       Date:  1959-11       Impact factor: 25.391

3.  Separation and characterization of two coeruloplasmins from human serum.

Authors:  L BROMAN
Journal:  Nature       Date:  1958-12-13       Impact factor: 49.962

4.  Thyroxinebinding by serum protein in pregnancy and in the newborn.

Authors:  J ROBBINS; J H NELSON
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

5.  Studies on serum copper during pregnancy, during the menstrual cycle, and after the administration of oestrogens.

Authors:  W VON STUDNITZ; D BEREZIN
Journal:  Acta Endocrinol (Copenh)       Date:  1958-02

6.  Influence of estrogens on total serum copper and caeruloplasmin.

Authors:  J RAYMUNT; E M RUSS
Journal:  Proc Soc Exp Biol Med       Date:  1956-07

7.  [Iron and copper metabolism in pregnant women and in newborn].

Authors:  S I DE VRIES
Journal:  Ned Tijdschr Verloskd Gynaecol       Date:  1953

8.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

9.  Oxidase reactions in human plasma caused by coeruloplasmin.

Authors:  C G HOLMBERG; C B LAURELL
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

10.  Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.

Authors:  H MARKOWITZ; C J GUBLER; J P MAHONEY; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808
View more
  8 in total

1.  BASAL COPPER EXCRETION IN WILSON'S DISEASE.

Authors:  C B WARREN; P M BROUGHTON
Journal:  Arch Dis Child       Date:  1964-06       Impact factor: 3.791

2.  Wilson's disease. The presenting symptoms.

Authors:  J M WALSHE
Journal:  Arch Dis Child       Date:  1962-06       Impact factor: 3.791

3.  Copper metabolism and the liver.

Authors:  J M WALSHE
Journal:  Postgrad Med J       Date:  1963-04       Impact factor: 2.401

4.  THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.

Authors:  I Sternlieb; A G Morell; W D Tucker; M W Greene; I H Scheinberg
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

5.  Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.

Authors:  A O Williams
Journal:  Br J Exp Pathol       Date:  1965-10

6.  A screening test for Wilson's disease and its application to psychiatric patients.

Authors:  D W Cox
Journal:  Can Med Assoc J       Date:  1967-01-14       Impact factor: 8.262

Review 7.  [Ceruloplasmin. I. Biochemistry of ceruloplasmin. II. Influence of estrogens on the ceruloplasmin content of the serum].

Authors:  A W Mondorf; G Mackenrodt; E Halberstadt
Journal:  Klin Wochenschr       Date:  1971-01-15

8.  Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease.

Authors:  Uta Merle; Karl Heinz Weiss; Christoph Eisenbach; Sabine Tuma; Peter Ferenci; Wolfgang Stremmel
Journal:  BMC Gastroenterol       Date:  2010-01-18       Impact factor: 3.067
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.